3-05-2011: General Shareholder Meeting Cellerix, S.A.
Junta General de Accionistas de lasociedad Cellerix, S.A. a celebrarse en el domicilio social el día 3 de mayo de2011, a las 11:00 horas,
Combination will create the European cell therapy leader with two marketed products and a promising pipeline
15-02-2011: CELLERIX DISCLOSES RESULTS OF PHASE IIa CLINICAL TRIAL OF Cx601 PRODUCT
Results and outcome of the study demonstrate very good safety and efficacy profiles
30-11-2009: Cellerix appoints José Luis Bravo VP Global Medical and Regulatory
10-11-2009: Cellerix raises €27 million in a first closing
YSIOS, LSP and VENTECH led this financing round together with Genetrix and also joined by new investors